Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Forges Collaboration with UC Davis to Validate miRNA Profile for Bladder Cancer

Premium

Rosetta Genomics this week announced that it is collaborating with the University of California, Davis, to develop and validate a microRNA profile for muscle-invasive bladder cancer that will help predict how patients will respond to neoadjuvant chemotherapy.

“A secondary goal of the study is to understand the mechanism by which differentially expressed microRNAs mediate chemosensitivity,” Rosetta said.

“Predicting responses to chemotherapy is becoming increasingly important with advances in oncology and
the introduction of molecularly targeted cancer drugs,” Rosetta President and CEO Kenneth Berlin said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.